Results 161 to 170 of about 5,022,759 (359)

Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic cancer

open access: yesMolecular Oncology, EarlyView.
Pancreatic ductal adenocarcinoma (PDAC) is a disease with very poor prognosis due to therapeutic limitations. We investigated the antitumor effects of cystatin A (CSTA) in PDAC murine models. We are first to confirm that CSTA enhances T helper type 1‐mediated antitumor effects through promotion of dendritic cells and M1 macrophage activity. CSTA can be
Alessandro Nasti   +8 more
wiley   +1 more source

Citizens’ Free Access to Information. The Case of Local Institutions from Rural Areas of the North-Western Region from Romania

open access: yesTransylvanian Review of Administrative Sciences
This study examines the extent to which local au­thorities in rural North-West Romania adhere to the requirements set forth in Law no. 544 of 2001, which mandates the ex officio public information disclo­sure online. The findings suggest a relatively low
Ioana Gabriela Bulău-Olaru   +2 more
doaj   +1 more source

Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer

open access: yesMolecular Oncology, EarlyView.
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia   +17 more
wiley   +1 more source

Understanding the impacts of the COVID-19 response measures on Deaf adults in Cape Town

open access: yesAfrican Journal of Disability
Background: International literature has evidenced that Deaf people have been disadvantaged during the COVID-19 pandemic; however, there is currently little research published within the South African context.
Charlotte Slome   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy